What Does InstaFan™ Cost?

A per-unit price estimate for OnePass Medical's multi-needle EUS-FNA/B disposable device — updated as quote data accrues

---

⚠️ Pricing transparency notice: MedSource does not yet hold aggregate quote data for InstaFan™. No manufacturer list price, GSA schedule entry, or distributor catalog price has been publicly confirmed as of May 2026. This article leads with what is verifiable from published specifications, regulatory filings, and the broader EUS-FNA/B disposable needle market. It will be updated as facility-level quotes are submitted.

---

InstaFan™ is positioned as a single-use, multi-needle EUS-FNA/B (Endoscopic Ultrasound–guided Fine Needle Aspiration/Biopsy) device platform, designed to collect biopsies simultaneously in one pass from five different locations in a tumor. Because it is a disposable, the procurement model is entirely consumable-based — there is no capital equipment purchase. All cost flows through per-procedure unit spend and any associated training or deployment support. Based on comparable complexity in the EUS accessory market and the device's novel multi-needle architecture, procurement teams should expect per-unit costs meaningfully above standard single-needle EUS-FNA/B needles, which publicly available distributor pricing places in the $150–$550 range depending on gauge (22G FNB vs. 25G FNA) and brand. InstaFan™'s 5-needle simultaneous-sampling design and therapeutic expansion potential suggest a significant premium over that baseline, but no verified list or contract price is publicly available at the time of publication.

---

What the Typical Range Is

No verified aggregate pricing exists for InstaFan™ at this time.

For reference, the published technical configuration of the device includes:

a 2.8 mm channel diameter, 1,400 mm total needle length, 80 mm deployment working zone, with both a 22G FNB and 25G FNA configuration, achieving a 10 mm fan spread at 30 mm deployment.

This multi-gauge, fan-out architecture is fundamentally more mechanically complex than the single-lumen needles that anchor the conventional EUS-FNA market (e.g., Boston Scientific Expect, Cook EchoTip Ultra, Medtronic SharkCore). Standard single-use 22G FNB needles from those competitors carry publicly listed distributor prices of roughly $300–$550 per unit; 25G FNA needles typically run $150–$350 per unit. A five-needle simultaneous-sampling device — plus the therapeutic delivery platform capability — would rationally command a per-unit premium, but the magnitude of that premium is unverifiable without direct supplier quotes.

Procurement officers at endoscopy units and gastroenterology ASCs should request a formal quote directly from OnePass Medical and cross-reference it against per-procedure EUS-FNA/B supply spend from their existing single-needle contracts before assessing value.

---

What Pushes Price Up — Features, Certifications, Support Tier

Multi-needle architecture: InstaFan collects multiple tissue samples from different areas of a tumor in a single procedure. The platform is particularly strong for EUS-guided biopsies and bronchoscopies, with potential to expand into therapeutic applications including multipronged drug delivery and ablation. Devices with dual diagnostic/therapeutic utility typically carry higher list prices than single-indication consumables.

Therapeutic pipeline configuration: InstaFan is described as the first and only solution enabling biopsies from 5 locations simultaneously, and with a slight modification can be used as a therapeutic delivery system for RF ablation, chemotherapy, biological drugs, and marking. If your facility is using it for intratumoral drug delivery in addition to biopsy, expect configuration-specific pricing tiers.

Clinical development status: OnePass Medical is a development-stage company , meaning volume-based pricing norms, competitive contract pressure, and GPO leverage are likely limited compared to mature EUS accessory markets. Early-adopter buyers have less pricing leverage than late-cycle buyers in established device categories.

Regulatory geography: InstaFan received ANVISA clearance (Brazil) in November 2021. US facilities should verify current FDA clearance status directly with the manufacturer before procurement, as regulatory standing directly affects liability exposure and reimbursement eligibility.

---

What Pushes Price Down — Refurbished, Older Generation, Lease, GPO Contracts

Single-use/disposable structure: There is no capital equipment chassis to amortize. The entire cost structure is consumable-per-procedure. This simplifies total cost of ownership modeling but removes refurbished or multi-use pathways.

Strategic collaborations: OnePass has two ongoing strategic development collaborations with Mayo Clinic, both of which include licensing agreements — the first focusing on GI applications, where first-in-man experiences have been completed. Facilities affiliated with or adjacent to Mayo's network may be able to negotiate collaborative-use pricing or access investigational pricing under institutional research frameworks.

Volume commitment: As a development-stage company seeking clinical adoption, OnePass Medical has structural incentives to offer preferred pricing to high-volume EUS centers willing to commit to case volume or generate outcomes data. Ask explicitly about volume-tiered pricing starting at as few as 25–50 units.

GPO access: No confirmed GPO contract (Vizient, Premiere, HealthTrust) for InstaFan™ has been publicly identified. Procurement teams should check current GPO portfolios directly and request the manufacturer pursue GPO listing if it is not already present.

---

Hidden Costs — Install, Training, Calibration, Consumables, Service Contracts

Physician and staff training: EUS-FNA is an established but technically demanding procedure; standard single-needle EUS-FNA already carries a false negative rate of up to 20–40%. InstaFan's five-needle fan deployment represents a distinct technique from conventional EUS-FNA. Budget for proctored case support (typically 3–10 supervised procedures) and any simulation or wet-lab training, which may or may not be included in initial contract terms.

Endoscope compatibility verification: The device requires a compatible working-channel linear echoendoscope. Confirm channel diameter compatibility (2.8 mm minimum) with your existing scope inventory before committing to volume. Incompatible scopes create either a capital equipment cost or a scope-rental/loan burden.

Pathology workflow costs: Simultaneous 5-site sampling increases specimen volume per case. This may require additional slide preparation, cytology review time, and cytotechnologist hours — costs borne by the pathology department, not the endoscopy budget. Coordinate with pathology before piloting.

Regulatory and compliance review: For US facilities, legal/compliance review of any device without a confirmed US FDA 510(k) clearance may be required before clinical use. Budget 2–6 weeks of internal review time and any associated legal fees.

No reusable capital equipment cost, but: Unlike capital devices with service contracts, there are no annual PM (preventive maintenance) or service agreement costs here. This is a pure consumable model.

---

How to Negotiate — Concrete Tactics

1. Request an itemized quote in writing specifying per-unit price, minimum order quantity, shipping terms, and shelf life. Development-stage companies sometimes default to verbal pricing — insist on written documentation.

2. Benchmark against your current EUS-FNA/B per-unit spend across all gauges and brands, then ask the rep to justify the per-procedure economics relative to your existing needle contract. Request a cost-per-adequate-sample calculation using InstaFan's published diagnostic yield data.

3. Negotiate proctored training into the contract as a line-item deliverable, not a verbal promise. Specify the number of supervised cases, the credential of the proctor (physician vs. clinical specialist), and the timeline.

4. Request a pilot evaluation agreement for 15–25 cases at a reduced or consignment price before converting to a standing purchase order. Development-stage companies frequently accept pilot terms to generate real-world data.

5. Ask about investigational pricing if your facility has research capacity. A site that can generate peer-reviewed outcomes data may be able to negotiate below commercial price in exchange for authorship/data-sharing arrangements.

6. Negotiate shelf-life guarantees and return terms. Single-use disposables carry expiration dates; if case volume projections miss, you carry inventory write-off risk. A 12-month minimum shelf life on delivered product and a restocking agreement should be standard asks.

---

When the Price Feels Off — Red Flags

• No written quote, only verbal pricing. For any single-use device purchased in clinical volume, insist on a formal written price sheet. Verbal price offers with no documentation are a sourcing control failure.

• No confirmed US FDA clearance documentation. If you are a US facility and the sales representative cannot produce a current FDA 510(k) clearance letter or De Novo authorization, stop the procurement process until regulatory status is independently verified via the FDA CDRH 510(k) database.

• Per-unit price below established single-needle EUS-FNA market rates. A per-unit price at or below standard single-needle EUS-FNA needles ($150–$350) for a 5-needle device would be implausible without a volume or investigational arrangement explicitly documented. Anomalously low pricing warrants scrutiny of product authenticity and supply chain provenance.

• Bundling of unvalidated therapeutic configurations. It is noted that InstaFan's therapeutic delivery platform is a near-future upgrade. Paying for RF ablation or drug delivery configurations that are not yet clinically validated or regulatory-cleared in your jurisdiction is premature spend. Confirm which specific configurations are cleared vs. investigational before purchasing.

• No minimum shelf life stated. Accepting delivery without a confirmed expiration date creates inventory compliance risk in any accredited facility.

---

Sources

1. OnePass Medical — InstaFan Product Page. Technical specifications (needle gauge, channel diameter, deployment geometry). onepassmedical.com/instafan

2. OnePass Medical — Pipeline Products Page. Therapeutic applications (RFA, intratumoral drug delivery). onepassmedical.com/pipeline-products

3. Galil Ofek Innovation / OnePass Medical One-Pager (April 2024). Market context (EUS-FNA false-negative rates, pancreatic cancer burden, InstaFan competitive positioning). galilofek.com/one-pass

4. Startup Nation Central — OnePass Medical Company Profile. Mayo Clinic collaboration details, platform description. finder.startupnationcentral.org

5. OnePass Medical — ANVISA Clearance Announcement (November 2021). Regulatory clearance in Brazil. onepassmedical.com/post/instafan-receives-anvisa-november-2021

6. FDA CDRH 510(k) Database. US clearance status should be independently verified at accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm prior to procurement.

---

This article will be updated as MedSource accrues facility-level quote data for InstaFan™. If your facility has received a formal quote, submit it to MedSource's pricing database to help benchmark this market.